ABL1 Mutation Analysis for Resistance to Imatinib Mesylate
18 days
Polymerase chain reaction (PCR), direct sequencing, capillary electrophoresis
Accredited Laboratory Partner
Contact Technical Support
Identifies mutations in the BCR-ABL1 gene. Used to evaluate resistance to tyrosine kinase inhibitors in CML.
Whole Blood or Bone Marrow
3 to 5 mL whole blood or 1 to 2 mL bone marrow
Lavender-top (EDTA) tube, green-top (sodium heparin) tube, yellow-top (ACD-A) tube, tan-top (K2-EDTA) tube or pink-top (K2-EDTA) tube
No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.
This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.
| Temperature | Period |
|---|---|
| Room temperature | 2 days |
ABL1 Mutation Analysis for Resistance to Imatinib Mesylate
18 days
Polymerase chain reaction (PCR), direct sequencing, capillary electrophoresis
Accredited Laboratory Partner
Contact Technical Support
Identifies mutations in the BCR-ABL1 gene. Used to evaluate resistance to tyrosine kinase inhibitors in CML.
Whole Blood or Bone Marrow
3 to 5 mL whole blood or 1 to 2 mL bone marrow
Lavender-top (EDTA) tube, green-top (sodium heparin) tube, yellow-top (ACD-A) tube, tan-top (K2-EDTA) tube or pink-top (K2-EDTA) tube
No special preparation is required for this test. You may eat, drink, and take your medications as normal, unless instructed otherwise by your healthcare provider.
This test does not require any special collection or pre-analytical handling. Follow routine specimen collection protocols.
| Temperature | Period |
|---|---|
| Room temperature | 2 days |